Download link:
.
.
==>
.
Immunopathology in Toxicology and Drug Development Volume 1, ISBN-13: 978-3319473758
.
<==
.
.
"Immunopathology in Toxicology and Drug Development Volume 1" explores the intricate relationship between the immune system and toxicological processes in the context of drug development. The book delves into various aspects of immunotoxicology, highlighting how environmental agents and pharmaceuticals can influence immune responses and contribute to adverse health outcomes. It provides a comprehensive overview of methodologies for assessing immunotoxicity, molecular mechanisms underlying immune system perturbations, and the implications for drug safety and efficacy. This volume serves as a critical resource for researchers and professionals in toxicology, pharmacology, and immunology, emphasizing the importance of understanding immunopathological responses in the development of safe and effective therapeutic agents.
.
Title: Immunopathology in Toxicology and Drug Development, Volume 1
ISBN-13: 978-3319473758
Authors: Various contributors
Publisher: Springer
Publication Year: 2016
Pages: 360
Series: Advances in Experimental Medicine and Biology
DOI: 10.1007/978-3-319-47376-5
Summary: This volume discusses the role of immunopathology in the context of toxicology and drug development, exploring mechanisms of immune response, pathology associated with toxic agents, and implications for drug safety assessment.
.
"Immunopathology in Toxicology and Drug Development Volume 1" serves as a comprehensive resource that bridges the gap between immunology, toxicology, and drug development. With its in-depth analysis and case studies, the book highlights the critical role of immune responses in evaluating the safety and efficacy of pharmaceuticals. It provides valuable insights into the mechanisms underlying immune-mediated toxicity, offering guidance for researchers and professionals in the field. By addressing current challenges and advancements in immunopathological research, this volume establishes a foundation for future innovations in drug safety assessment and therapeutic development.
.
